Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Sionna Therapeutics, Inc. (SION) had Return on Investments of 37.68% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-61.69M |
|
-- |
|
-- |
|
$70.56M |
|
$-70.56M |
|
$8.87M |
|
$-61.69M |
|
$-61.69M |
|
$-61.69M |
|
$-61.69M |
|
$-61.69M |
|
$-61.69M |
|
$-70.56M |
|
$-72.89M |
|
3.86M |
|
3.86M |
|
$-15.99 |
|
$-15.99 |
|
| Balance Sheet Financials | |
$150.99M |
|
$2.47M |
|
$34.76M |
|
$185.75M |
|
$10.42M |
|
-- |
|
$339.05M |
|
$349.46M |
|
$-163.71M |
|
$-163.71M |
|
$-163.71M |
|
-- |
|
| Cash Flow Statement Financials | |
$-52.79M |
|
$-126.91M |
|
$178.97M |
|
$39.48M |
|
$38.75M |
|
$-0.73M |
|
$3.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-52.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
37.68% |
|
37.68% |
|
-33.21% |
|
|
Return on Investments |
37.68% |
-- |
|
$-13.69 |
|
$-13.68 |
|